First Report of Manic-Like Symptoms in a COVID-19 Patient with No Previous History of a Psychiatric Disorder

Shaojia Lu,Ning Wei,Jiajun Jiang,Lingling Wu,Jifang Sheng,Jianying Zhou,Qiang Fang,Yu Chen,Shufa Zheng,Feng Chen,Tingbo Liang,Shaohua Hu
DOI: https://doi.org/10.1016/j.jad.2020.08.031
IF: 6.533
2020-01-01
Journal of Affective Disorders
Abstract:BACKGROUND:In December 2019, the novel coronavirus (SARS-CoV-2) infection was first reported in Wuhan city, central China, which has spread rapidly. The common clinical features of patients with SARS-CoV-2 infection included fever, fatigue, and damage to the respiratory or digestive system. However, it is still unclear whether SARS-CoV-2 infection could cause damage to the central nervous system (CNS) inducing psychiatric symptoms.CASE REPORT:Herein, we present the first case of SARS-CoV-2 infection with manic-like symptoms and describe the diagnosis, clinical course, and treatment of the case, focusing on the identifications of SARS-CoV-2 in the specimen of cerebrospinal fluid (CSF). The patient developed manic-like symptoms when his vital signs recovered on illness day 17. After manic-like attack, the detection of SARS-CoV-2 specific IgG antibody in CSF was positive, while the reverse transcriptase-polymerase chain reaction (RT-PCR) on CSF for the SARS-CoV-2 was negative. The patient received Olanzapine for treatment and his mood problems concurrently improved as indicated by scores of Young Manic Rating Scale (YMRS).LIMITATION:This is a single case report only, and the RT-PCR test for SARS-CoV-2 in CSF was not performed simultaneously when SARS-CoV-2 was positive in samples of sputum and stool.CONCLUSION:This first case of COVID-19 patient with manic-like symptoms highlights the importance of evaluation of mental health status and may contribute to our understanding of potential risk of CNS impairments by SARS-CoV-2 infection.
What problem does this paper attempt to address?